Vical to Present at the 18th Annual Rodman & Renshaw Global Investment Conference
September 02 2016 - 6:30AM
Vical Incorporated (Nasdaq:VICL) today announced that the company
will provide an overview of its technologies, development programs,
and outlook on Monday, September 12, at 11:40 a.m. ET at the 18th
Annual Rodman & Renshaw Global Investment Conference, sponsored
by H.C. Wainwright & Co., LLC. The conference is being
held on September 11-13, 2016, at Lotte New York Palace Hotel
in New York City. A webcast of the company’s presentation will be
available live and archived through the Events & Presentations
page in the Investors section of the Vical website at
www.vical.com.
About VicalVical develops
biopharmaceutical products for the prevention and treatment of
chronic or life-threatening infectious diseases, based on its
patented DNA delivery technologies and other therapeutic
approaches. Additional information on Vical is available at
www.vical.com.
Contact:
Andrew Hopkins
(858) 646-1127
Website: www.vical.com
Vical (NASDAQ:VICL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vical (NASDAQ:VICL)
Historical Stock Chart
From Sep 2023 to Sep 2024